Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyMyelomaTeam Member asked a question 💭
Taylors, SC
July 31
 · 
Reactions
A MyMyelomaTeam Member

Praise God! That is wonderful!

August 1
A MyMyelomaTeam Member

They rejected me for SCT in 2008 at Johns Hopkins Hospital in Baltimore. In 2010, I was taken off chemo since there were no longer bad cells in my bloodwork. I've been off chemo since then. I'm 84, shooting for 100. MM cost me both knees and 6" of spine.

August 1
MyMyelomaTeam

Are there myeloma patients who don't need medication after a stem cell transplant?

After a stem cell transplant for myeloma, most patients do require some form of ongoing medication. Maintenance therapy is considered a standard part of care following a transplant.

Here's what's typically involved:

- Autologous transplant Show Full Answer

Are there myeloma patients who don't need medication after a stem cell transplant?

After a stem cell transplant for myeloma, most patients do require some form of ongoing medication. Maintenance therapy is considered a standard part of care following a transplant.

Here's what's typically involved:

- Autologous transplant recipients usually receive several years of maintenance medications to help sustain the treatment response
- Allogeneic transplant recipients may need to take antirejection medication for life to prevent complications

Lenalidomide is the most commonly used maintenance therapy after a transplant. Studies have shown it can sustain remission significantly longer compared to no maintenance treatment. It's worth noting that every person's situation is different, and treatment decisions are highly individualized. A healthcare team will assess factors like remission depth, overall health, and minimal residual disease (MRD) status when deciding on a maintenance plan.

It's always best to have an open conversation with your specialist about what post-transplant care looks like for your specific situation.

July 31

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭
Rawdon

A MyMyelomaTeam Member asked a question 💭
Taylors, SC